ARQT
NASDAQ · Biotechnology
Arcutis Biotherapeutics Inc
$21.17
+0.51 (+2.47%)
Performance
1D
—
1W
—
1M
—
3M
-21.24%
6M
-10.86%
1Y
+56.47%
YTD
-27.00%
Open$20.71
Previous Close$20.66
Day High$21.36
Day Low$20.26
52W High$31.77
52W Low$12.42
Volume—
Avg Volume1.68M
Market Cap2.58B
P/E Ratio—
EPS$-0.13
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$27.64
Below
SMA 200
$20.38
Above
RSI (14)
67.5
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
14 analysts
Price Target
+305.2% upside
Current
$21.17
$21.17
Target
$85.78
$85.78
$74.20
$85.78 avg
$112.10
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 360.79M | 947.52M | 972.47M |
| Net Income | -15,489,433 | 179.95M | 161.28M |
| Profit Margin | -4.3% | 19.0% | 16.6% |
| EBITDA | -11,302,769 | 271.10M | 315.26M |
| Free Cash Flow | — | 104.36M | 84.89M |
| Rev Growth | +367.1% | -4.3% | +9.4% |
| Debt/Equity | 0.58 | 0.78 | 0.80 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $201.55 | -0.57% | 88.1 | 372.29B |
| AMGN | Amgen Inc | $331.70 | +0.79% | 22.7 | 176.88B |
| GILD | Gilead Sciences Inc | $131.33 | -2.04% | 19.3 | 163.92B |
| VRTX | Vertex Pharmaceuticals Inc | $429.82 | +1.13% | 27.7 | 109.50B |
| REGN | Regeneron Pharmaceuticals | $714.89 | +0.82% | 16.5 | 74.30B |
| ALNY | Alnylam Pharmaceuticals Inc | $295.05 | -0.29% | 130.4 | 40.90B |